Alzheimer's disease: Cardiovascular risk factors must be assessed;Maladie d'Alzheimer: Prendre en compte les facteurs de risque et pathologies cardiovasculaires

Revue de Medecine Interne

Volumn 27, Issue 1, 2006, Pages 21-31

  Antoine, V ^a   Rigaud, A S ^b  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b Paris Descartes University   (France)

Author keywords

Alzheimer's disease; Elderly; Vascular dementia; Vascular risk factors

Indexed keywords

AMYLOID; BENDROFLUMETHIAZIDE; CANDESARTAN; DILTIAZEM; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; MEDROXYPROGESTERONE ACETATE; NITRENDIPINE; PERINDOPRIL;

ALZHEIMER DISEASE; ARTERIOSCLEROSIS; ARTERY WALL; BRAIN PERFUSION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITIVE DEFECT; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DEMENTIA; EPIDEMIOLOGICAL DATA; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; NEUROIMAGING; NEUROPATHOLOGY; NEUROTOXICITY; PATHOPHYSIOLOGY; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION;

EID: 29944441816     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2005.04.037     Document Type: Short Survey

References (124)

1. H. Ramaroson, C. Helmer, P. Barbeger-Gateau, L. Letenneur, and J.F. Dartigues PAQUID:: Pŕvalence de la d́mence et de la maladie d'Alzheimer chez les personnes de 75:ans et plus:: donńes ŕactualiśes de la cohorte PAQUID Rev. Neurol. 15 2003 405 411
2. A. Lobo, L.J. Launer, L. Fratiglioni, K. Andersen, M.M. Breteler, and J.R. Copelend Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts Neurol. 54 suppl 5 2000 S4 S9
3. L. Fratiglioni, L.J. Launer, L. Andersen, K. Breteler, M.M. Copelend Jr., and J.F. Dartigues Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts Neurol. 54 suppl 5 2000 S10 S15
4. A. Di Carlo, L.J. Launer, M.M. Breteler, L. Fratiglioni, A. Lobo, and J. Martinez-Lage Frequency of stroke in Europe: a collaborative study of population-based cohorts Neurol. 54 suppl 5 2000 S28 S33
5. C. Duyckaerts, M.A. Colle, B. Delatour, and J.J. Hauw Maladie d'Alzheimer:: les ĺsions et leur progression Rev. Neurol. 155 4S 1999 17 27
6. D. Zekry, J.J. Hauw, and G. Gold Mixed dementia: epidemiology, diagnosis and treatment J. Am. Geriatr. Soc. 50 2002 1431 1438
7. T. Ostbye, G. Hill, and R. Steenhuis Mortality in elderly Canadians with and without dementia: a 5-year follow-up Neurol. 53 1999 521 526
8. W.A. Kukull, D.E. Brenner, C.E. Speck, D. Nochlin, J. Bowen, and W. McCormick Causes of death associated with Alzheimer's disease: variation by level of cognitive impairment before death J. Am. Geriatr. Soc. 4 1994 723 726
9. J. Keene, T. Hope, C.G. Fairburn, and R. Jacoby Death and dementia Int J Geriatr Psychiatry 16 2001 969 974
10. R.S. Tilvis, M.H. Kahonen-Vare, J. Jolkkonen, J. Valvanne, K.H. Pitkala, and T.E. Strandberg Predictors of cognitive decline and mortality of aged people over a 10-year period J. Gerontol. A Biol. Sci. Med. Sci. 59 2004 268 274
11. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. (Berl.) 82 1991 239 259
12. A. Delacourte, J.P. David, and F. Ghozali Les ĺsions ćŕbrales de la maladie d'Alzheimer B.F. Michel C. D́rouesń M.C. Gely-Nargeot De la plainte mńsique ̀ la MA 1997 Solal 29 39
13. Neuropathology Group of the MRC CFAS Pathological correlates of late-onset dementia in a multicenter, community-based population in England and Wales Lancet 357 2001 169 175
14. R.N. Kalaria Small vessel disease and Alzheimer's dementia: pathological considerations Cerebrovasc. Dis. 13 suppl 2 2002 48 52
15. G.C. Roman Vascular dementia may be the most common form of dementia in the elderly J. Neurol. Sci. 203 2002 7 10
16. K.A. Jellinger, and J. Attems Incidence of cerebrovascular lesions in Alzheimer's disease: a post-mortem study Acta Neuropathol. (Berl.) 105 2003 14 17
17. J.C. De la Torre Alzheimer's disease is a vasocognopathy: a new term to describe its nature Neurol. Res. 26 2004 517 524
18. J.C. De la Torre Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma and dialectics Lancet Neurol. 3 2004 184 190
19. D.R. Thal, E. Ghebremedhin, M. Orantes, and O.D. Wiestler Vascular pathology in Alzheimer's disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline J. Neuropathol. Exp. Neurol. 62 2003 1287 1301
20. D. Zekry, C. Duyckaerts, J. Belmin, C. Geoffre, R. Moulias, and J.J. Hauw Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia Acta Neuropathol. (Berl.) 106 2003 367 373
21. A.A. Rensik, R.M. de Waal, B. Kremer, and M.M. Verbeek Pathogenesis of cerebral amyloid angiopathy Brain Res Rev. 43 2003 207 223
22. J. Tian, J. Shi, K. Bailey, and D.M. Mann Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease Neuropathol. Appl. Neurobiol. 30 2004 46 56
23. M. Yamada Risk factors for cerebral amyloid angiopathy in the elderly Ann. N. Y. Acad. Sci. 977 2002 37 44
24. J. Tian, J. Shi, K. Bayley, and D.M. Mann Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer's disease Neurosci. Lett. 352 2 2003 137 140
25. J.A. Nicoll, D. Wilkinson, C. Holmes, B. Steart, H. Markham, and R.O. Weller Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report Nat. Med. 9 2003 448 452
26. T. Revesz, J. Ghiso, T. Lashley, G. Plant, A. Rostagno, and B. Frangione Cerebral amyloid angiopathy: a pathologic, biochemical and genetic view J. Neuropathol. Exp. Neurol. 62 2003 885 898
27. R.O. Weller, and J.A. Nicoll Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain Neurol Res. 25 2003 611 616
28. M. Haglund, and E. Englund Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy: a histopathological assessment Dement. Geriatr. Cogn. Disord. 14 2002 161 166
29. L.A. Pfeifer, L.R. White, G.W. Ross, H. Petrovitch, and L.J. Launer Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study Neurol. 58 2002 1629 1634
30. K.A. Jellinger, and E. Mitter-Ferstl The impact of cerebrovascular lesions in Alzheimer's disease - a comparative autopsy study J. Neurol. 250 2003 1050 1055
31. K.A. Jellinger Prevalence of vascular lesions in dementia with Lewy bodies. A post mortem study J. Neural Transm. 110 2003 771 778
32. K.A. Jellinger Prevalence of vascular lesions in Parkinson's disease. A post mortem study Acta Neuropathol. (Berl.) 105 2003 415 419
33. D.A. Snowdon, L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner, and W.R. Markesbery Brain infarction and the clinical expression of Alzheimer's disease. The nun study JAMA 277 1997 813 817
34. D. Zekry, C. Duyckaerts, R. Moulias, J. Belmin, C. Geoffre, and F. Hermann Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly Acta Neuropathol. (Berl.) 103 2002 481 487
35. M.M. Esisri, Z. Nagy, M.Z. Smith, L. Barnetson, and A.D. Smith Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease Lancet 364 1999 919 920
36. M. Liebetrau, B. Steen, G.F. Hamman, and I. Skoog Silent and symptomatic infarcts on cranial computarized tomography in relation to dementia and mortality: a population-based study in 85-year-old subjects Stroke 35 2004 1816 1820
37. D. Zekry, C. Duyckaerts, J. Belmin, C. Geoffre, F. Hermann, and R. Moulias The vascular lesions in vascular and mixed dementia: the weight of functionnal neuroanatomy Neurobiol. Aging 24 2003 213 219
38. D.J. Selkoe Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and toxicity of amyloid beta-protein Ann. N. Y. Acad. Sci. 924 2000 17 25
39. P.B. Gorelick Risk factors for vascular dementia and Alzheimer disease Stroke 35 suppl1 2004 2620 2622
40. G.C. Roman, and D.R. Royall A diagnostic dilemna: is « Alzheimer's dementia » Alzheimer's disease, vascular disease or both? Lancet Neurol. 3 2004 141
41. I. Casserly, and E. Topol Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol and misfolded proteins Lancet 363 2004 1139 1146
42. J.M. Goulding, D.F. Signorini, S. Chatterjee, J.A. Nicoll, J. Stewart, and R. Morris Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia J. Neurol. Neurosurg. Psychiatry 67 1999 654 657
43. J. Corey-Bloom, D. Galasko, and C.R. Hofstetter Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia J. Am. Geriatr. Soc. 41 1993 31 37
44. K. Rockwood, C. Macknight, and C. Wentzel The diagnosis of mixed dementia in the consortium for the investigation of vascular impairment of cognition Ann. N. Y. Acad. Sci. 903 2000 522 528
45. S. Love, J.A. Nicoll, A. Hughes, and G.K. Wilcock ApoE and cerebral amyloid angiopathy in the elderly Neuroreport 14 2003 1535 1536
46. J.J. Hauw, D. Zekry, D. Seilhean, B. Forette, C. Gallinari, and M. Laurent Neuropathology of the cerebral vessels of centenarians J. Mal. Vasc. 27 2002 S13 S18
47. O. Kosunen, S. Talasniemi, and M. Lehtovirta Relation of coronary heart atherosclerosis and apoE genotypes in Alzheimer's patients Stroke 26 1995 743 748
48. A. Hofman, A. Ott, and M.M. Breteler Atherosclerosis, ApoE, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study Lancet 349 1997 151 154
49. J. Tian, J. Shi, K. Bailey, J.M. Harris, A. Pritchard, and J.C. Lambert A polymorphism in the angiotensin 1 converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease Neurosci. Lett. 354 2004 103 106
50. V. Hachinski, and C. Iadecola Vascular cognitive impairment Stroke 35 suppl1 2004 2615
51. J.T. Moroney, E. Bagiella, D.W. Desmond, V.C. Hachinski, P.K. Molsa, and L. Gustafson Meta-analysis of the Hachinski ischemic score in pathologically verified dementias Neurol. 49 1997 1096 1105
52. D. Zekry, C. Duyckaerts, J. Belmin, C. Geoffre, R. Moulias, and J.J. Hauw Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology J. Neurol. 249 2002 1529 1534
53. D.S. Knopman, J.E. Parisi, B.F. Boeve, R.H. Cha, H. Apaydin, and A. Salviati Vascular dementia in a population-based autopsy study Arch. Neurol. 60 2003 569 575
54. T. Pohjasvaara, R. Mantyla, R. Ylikoski, M. Kaste, and T. Erkinjuntii Comparaison of different clinical criteria (DSMIII, ADDTC, ICD 10, NINDS-AIREN, DSMIV) for the diagnosis of vascular dementia). AINDS-AIREN Stroke 31 2000 2952 2957
55. R.N. Kalaria Small vessel disease and Alzheimer's dementia: pathological considerations Cerebrovasc. Dis. 13 suppl 2 2002 48 52
56. C. Derouesń La fŕquence relative des diff́rentes affections d́mentielles: les donńes de la banque de cerveaux de Floride Psychol. Neuropsychiatr. Vieillissement 1 2003 139 140
57. A. Di Carlo, L.J. Launer, M.M. Breteler, L. Fratiglioni, A. Lobo, and J. Martinez-Lage Frequency of stroke in Europe: a collaborative study of population-based cohorts Neurol. 54 suppl 5 2000 S28 S33
58. R.L. Sacco, E.J. Benjamin, J.P. Broderick, M. Dyken, J.D. Easton, and W.M. Feinberg AHA prevention conference. Prevention and rehabilitation of stroke. Risk factors Stroke 28 1997 1507 1517
59. J.T. Moroney, E. Bagiella, T.K. Tatemichi, M.C. Paik, Y. Stern, and D.W. Desmond Dementia after stroke increases the risk of long-term stroke recurrence Neurol. 48 1997 1317 1325
60. L.S. Honig, M.X. Tang, S. Albert, R. Costa, J. Luchsinger, and J. Manly Stroke and the risk of Alzheimer's disease Arch. Neurol. 60 2003 1707 1712
61. T. Erkinjuntii Diagnosis and management of vascular cognitive impairment and dementia J. Neural Transm. 63 suppl 2002 91 109
62. H. H́non, F. Pasquier, I. Durieu, O. Godefroy, C. Lucas, and F. Lebert Pre-existing dementia in stroke patients. Baseline frequency, associated factors and outcome Stroke 28 1997 2429 2436
63. A.E. Roher, and C. Esh RAhman A, Kokjohn TA, Beach TG: Atherosclerosis of cerebral arteries in Alzheimer's disease Stroke 35 suppl 1 2004 2623 2627
64. S.E. Vermeer, N.D. Prins, T. Den Heijer, A. Hoffman, P.J. Koudstaal, and M.M. Breteler Silent brain infarcts and the risk of dementia and cognitive decline N. Engl. J. Med. 348 2003 1215 1222
65. J.S. Meyer, G. Xu, J. Thornby, M.H. Chowdhury, and M. Quach Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? Stroke 33 2002 1981 1985
66. F. Forette, M.L. Seux, J.A. Staessen, L. Thijs, W.H. Birkenhäger, and M.R. Babarskiene Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial Lancet 352 1998 1347 1351
67. C. Tzourio, C. Anderson, N. Chapmann, M. Woodward, B. Neal, S. Mac Mahon PROGRESS collaborative group Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease Arch. Intern. Med. 163 2003 1069 1075
68. M.M. Esiri, Z. Nagy, M.Z. Smith, L. Barnetson, and A.D. Smith Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease Lancet 354 1999 919 920
69. G.C. Roman Vascular dementia: distinguishing characteristics, treatment and prevention Am. Geriatr. Soc. 51 suppl5 2003 S296 S304
70. F. Gueyffier, C. Bulpitt, J.P. Boissel, E. Schron, T. Ekbom, and R. al Fagard Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials Lancet 353 1999 793 796
71. C.D. Mulrow, J.A. Cornell, C.R. Herrera, A. Kadri, L. Farnett, and C. Aguilar Hypertension in the elderly. Implications and generalizability of randomized trials JAMA 272 1994 1932 1938
72. H. Lithell, L. Hansson, I. Skoog, D. Elmfeldt, A. Hofman, and B. Olofsson The study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial J. Hypertens. 21 2003 875 886
73. C.J. Bulpitt, N.S. Beckett, J. Cooke, D.L. Dumitrascu, B. Gil-Extremera, and C. Nachev Results of the pilot study for the hypertension in the very elderly trial (HYVET) J. Hypertens. 21 12 2003 2409 2417
74. J.A. Staessen, and J. Wang Blood-pressure lowering for the secondary prevention of stroke Lancet 358 2001 1026 1027
75. S. Kamath, and G.Y. Lip Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly Am. J. Geriatr. Cardiol. 11 2002 357 362
76. M. Barber, R.C. Tait, J. Scott, A. Rumley, G.D. Lowe, and D.J. Stott Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation J. Thromb. Haemost. 2 2004 1873 1878
77. M. Nelson, C. Reid, L. Beilin, G. Donnan, C. Johnston, and H. Krum Rationale for a trial of low-dose aspirin fort he primary prevention of major adverse cardiovascular events and vascular dementia in the elderly (ASPREE) Drugs Aging 20 2003 897 903
78. J. Sheperd, G.J. Blauw, M.B. Murphy, E. Bollen, B.M. Buckley, and S.M. Cobbe Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 2002 1623 1630
79. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial Lancet 360 2002 7 22
80. W.S. Aronow Effects of statins on mortality and cardiovascular events in elderly high-risk persons J. Am. Geriatr. Soc. 51 2003 718
81. J.M. Foody, and H.M. Krumholz Are statins indicated for the primairy prevention of CAD in octogenarians? Antagonist viewpoint Am. J. Cardiol. 12 2003 357 360
82. L.J. Miller, and R. Chacko The role of cholesterol and statins in Alzheimer's disease Ann. Pharmacother. 38 2004 91 98
83. D.S. King, A.J. Wilburn, M.R. Wofford, T.K. Harrel, B.J. Lindley, and D.W. Jones Cognitive impairment associated with atorvastatin and simvastatin Pharmacother. 23 2003 1663 1667
84. L.R. Wagstaff, M.W. Mitton, B.M. Arvik, and P.M. Doraiswamy Statin-associated memory loss: analysis of 60 case reports and review of the litterature Pharmacother. 23 2003 871 880
85. B. Borroni, C. Pettenati, T. Bordolani, N. Akkawi, M. Di Luca, and A. Padovani Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer's dissease Neurosci. Lett. 343 2003 213 215
86. H. Ĺvesque Les effets non lipidiques des statines au cours de l'ath́roscĺrose Rev. Med. Intern. 25 2004 783 785
87. S.A. Shumaker, C. Legault, L. Kuller, S.R. Rapp, L. Thal, and D.S. Lane Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in post-menopausal women JAMA 291 2004 2947 2958
88. S. Wasser-Theil, S.L. Hendrix, M. Limacher, G. Heiss, C. Kooperberg, and A. Baird Effect of estrogen plus progestin on stroke in post-menopausal women: WHIM study JAMA 289 2003 2673 2684
89. K.A. Jellinger, and E. Mitter-Ferstl The impact of cerebrovascular lesions in Alzheimer's disease - a comparative autopsy study J. Neurol. 250 2003 1050 1055
90. G.S. Alexopoulos, B.S. Meyers, R.C. Young, T. Kakuma, D. Silbersweig, and M. Charlson Clinically defined vascular depression Am. J. Psychiatry 154 1997 562 565
91. J.C. De Groot, F.E. de Leeuw, M. Oudkerk, A. Hofman, J. Jolles, and M.M. Breteler Cerebral white matter lesions and depressive symptoms in elderly adults Arch. Gen. Psychiatry 57 2000 1071 1076
92. T. Fujikawa, S. Yamawaki, and Y. Touhouda Incidence of silent cerebral infarction in patients with major depression Stroke 24 1993 1631 1634
93. H. Susuki, and M. Saruta Calcium Antagonist in Progressive Renal Insufficiency Study Group: Effects of Calcium Antagonist, benidipine, on the progression of chronic renal failure in the elderly: a 1-year follow-up Clin. Exp. Hypertens. 23 2001 189 201
94. G. Maschio, D. Alberti, G. Janin, F. Locatelli, J.F. Mann, and M. Motolese Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The A-C-E Inhibition in Progressive Renal Insufficiency Study Group N. Engl. J. Med. 334 1996 939 945
95. L. V́nat, V. Loustaud-Ratti, E. Liozon, P. Soria, S. Nadalon, and V. Gissot H́patosid́roses dysḿtaboliques, caract́ristiques chez 51 patients Presse Med. 32 2003 400 406
96. T.Y. Wong Is retinal photography useful in the measurement of stroke risk? Lancet Neurol. 3 2004 179 183
97. S. Seshadri, A. Beiser, J. Sellhub, P.F. Jacques, I.H. Rosenberg, and R.B. D'Agostino Plasma homocysteine as a risk factor for dementia and Alzheimer's disease N. Engl. J. Med. 346 2002 476 493
98. M. Malouf, E.J. Grimley, and S.A. Aerosa Folic acid with or without vitamin B12 for cognition and dementia Cochrane Database Syst. Rev. 2003 [(4)CD004514]
99. Y. Schwammenthal, and D. Tanne Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials Lancet Neurol. 3 2004 493 495
100. A.S. Rigaud, G. Andŕ, B. Vellas, J. Touchon, J.J. Pere, and Y. Loria-Kanza Traitement estroprogestatif en association avec la rivastigmine chez des femmes ḿnopauśes atteintes de la maladie d'Alzheimer. Ŕsultats d'une ́tude contrôĺe sur 28 semaines Presse Med. 32 2003 1649 1654
101. O. Hanon, F. Latour, M.L. Seux, H. Lenoir, F. Forette, A.S. Rigaud et le groupe REAL.FR Relations entre la pression art́rielle et les fonctions cognitives. Donńes du ŕseau fraņais sur la maladie d'Alzheimer REAL.FR Rev. Med. Int. 24 suppl3 2003 292 300
102. T. Voisin, S. Lugardon, L. Balardy, and B. Vellas Facteurs de risque vasculaires et maladie d'Alzheimer Rev. Med. Intern. 24 suppl3 2003 S288 S291
103. C. Qiu, E. von Strauss, B. Winblad, and L. Fratiglioni Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project Stroke 35 2004 1810 1815
104. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, and L. Nilsson 15-year longitudinal study of blood-pressure and dementia Lancet 347 1996 1141 1145
105. Z. Guo, M. Viitanen, L. Fratiglioni, and B. Winblad Low blood pressure and dementia in elderly people: the Kungsholmen project BMJ 312 1996 805 808
106. A. Cohen-Solal, M. Desnos, F. Delahaye, J.P. Emeriau, and G. Hanania A national survey of heart failure in french hospitals. The myocardiopathy and Heart Failure Working Group of the french society of cardiology, the national college of general hospitals cardiologists and the french geriatric society Eur. Heart J. 21 2000 763 769
107. J.P. Emeriau, N. Salles, L. Mazat, T. Traissac, I. Bourdel-Marchasson, and M. Rainfray Cholest́rol et vieillissement Âge Nutr. 14 2003 177 179
108. P. Quadri, C. Fragiacomo, R. Pezzati, E. Zanda, G. Forloni, and M. Tattamanti Homocysteine, folate and vitamin B12 in mild cognitive impairment, Alzheimer disease and vascular dementia Am. J. Clin. Nutr. 80 2004 114 122
109. N. Salles-Montaudon, F. Parrot, D. Balas, E. Bouzigon, M. Rainfray, and J.P. Emeriau Prevalence and mechanisms of hyperhomocysteinemia in elderly hospitalised patients J. Nutr. Health Aging 7 2003 111 116
110. J.L. Schlienger, S. Vinzio, A. Pradignac, F. Grunenberger, and B. Goichot Statines et risques ćŕbrocardiovasculaires chez les personnes âǵes Rev. Med. Intern. 25 2004 801 805
111. D. Minier, G.V. Osseby, G. Couvreur, T. Moreau, and M. Giroud Accidents vasculaires ćŕbraux: ́pid́miologie actualiśe Neurol. 5 2002 222 231
112. R.A. Kenny, R. Kalaria, and C. Ballard Neurocardiovascular instability in cognitive impairment and dementia Ann. N. Y. Acad. Sci. 977 2002 183 195
113. J. Boddaert, and J. Belmin L'hypotension orthostatique du sujet âǵ et son traitement Presse Med. 32 2003 1707 1715
114. S. Pariel-Madjlessi, and C. Oasi Letonturier:: Conśquences cliniques de l'hypox́mie au niveau ćŕbral chez le sujet âǵ Rev. Geriat. 26 2001 371 378
115. G.C. Roman Vascular dementia may be the most common form of dementia in the elderly J. Neurol. Sci. 203 2002 7 10
116. G.C. Roman, T. Erkinjuntti, A. Wallin, L. Pantoni, and H.C. Chui Subcortical ischaemic vascular dementia Lancet Neurol. 1 2002 426 436
117. L. Pantoni, and J.H. Garcia Pathogenesis of leukoaraiosis: a review Stroke 28 1997 652 659
118. G.C. Roman Vascular dementia revisited: diagnosis, pathogenesis, treatment and prevention Med. Clin. North Am. 86 2002 477 499
119. E.A. Milward, D.A. Grayson, H. Creasey, M.R. Janu, W.S. Brooks, and G.A. Broe Evidence for association of anaemia with vascular dementia Neuroreport 10 1999 2377 2381
120. C.D. Furberg, B.M. Psaty, T.A. Manolio, J.M. Gardin, V.E. Smith, and P.M. Rautaharju Prevalence of atrial fibrillation in elderly subjects. The Cardio-vascular Health Study Am. J. Cardiol. 74 1994 236 241
121. S. Ferchichi, and V. Antoine Du bon usage du ḿdicament chez la personne âǵe Rev. Med. Intern. 25 2004 582 590
122. J.T. Moroney, C.L. Tseng, M.C. Palk, J.P. Mohr, and D.W. Desmond Treatment for the secondary prevention of stroke in older patients: the influence of dementia status J. Am. Geriatr. Soc. 47 1999 824 829
123. M. Man-Son-Hing, G. Nichol, A. Lau, and A. Laupacis Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls Arch. Intern. Med. 9 1999 20 23
124. G. Bellelli, A. Bianchetti, and M. Trabucchi Anticoagulation to prevent stroke in atrial fibrillation. Comprehensive geriatric evaluation should be routine before treatment is started BMJ 321 2000 1157